Literature DB >> 3882773

Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication.

H R Dettelbach, D M Aviado.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882773     DOI: 10.1002/j.1552-4604.1985.tb02796.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  25 in total

Review 1.  β-thalassemia intermedia: a clinical perspective.

Authors:  Khaled M Musallam; Ali T Taher; Eliezer A Rachmilewitz
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

2.  Effect of pentoxifylline on liver plasma flow in normal man.

Authors:  A Suren; F E Bauer; B Rosenkranz; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Pentoxifylline does not improve outcome in a murine model for the multiple-organ dysfunction syndrome.

Authors:  T J H Volman; R J A Goris; T Hendriks
Journal:  Intensive Care Med       Date:  2005-02-15       Impact factor: 17.440

4.  Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells.

Authors:  Peeyush N Goel; R P Gude
Journal:  Mol Cell Biochem       Date:  2011-07-03       Impact factor: 3.396

5.  Pentoxifylline attenuates ischemia/reperfusion injury to the small intestine in the rat.

Authors:  R Udassin; A Vromen; D Seror; Y Haskel
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

6.  Band 3 antagonists, p-azidobenzylphlorizin and DIDS, mediate erythrocyte shape and flexibility changes as characterized by digital image morphometry and microfiltration.

Authors:  D M Hoefner; M E Blank; B M Davis; D F Diedrich
Journal:  J Membr Biol       Date:  1994-07       Impact factor: 1.843

7.  Pentoxifylline does not reduce infarct size in a canine model of acute myocardial infarction.

Authors:  C A Campbell; C F Clavenna; J Wynne; R A Kloner
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

8.  Pentoxifylline attenuates acute lung injury induced by microemboli.

Authors:  C Y Shen; K Hsu; D Wang; H C Yan
Journal:  Experientia       Date:  1995-09-29

9.  Effects of pentoxifylline (Trental) on blood flow, viscosity, and oxygen transport in young adults with inoperable cyanotic congenital heart disease.

Authors:  W Berman; N Berman; D Pathak; S C Wood
Journal:  Pediatr Cardiol       Date:  1994 Mar-Apr       Impact factor: 1.655

Review 10.  Intermittent claudication: new targets for drug development.

Authors:  Eric P Brass
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.